ANN ARBOR, MI -- (MARKET WIRE) -- February 20, 2007 -- Pipex Pharmaceuticals, Inc. (OTCBB: PPXP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today the appointment of Daniel J. Dorman and Dr. James S. Kuo to the board of directors of Pipex.
